【正文】 et al. ACC/AHA/NASPE 2021 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2021. Available at IIb 類適應(yīng)證 : 慢性雙分支和三分支阻滯的起搏治療 ? 神經(jīng)肌源性疾病伴發(fā)任何程度的分支阻滯，無論是否有癥狀，因為傳導(dǎo)阻滯可能隨時加重。 Gregoratos G. et al. ACC/AHA/NASPE 2021 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2021. Available at III 類適應(yīng)證 : 獲得性房室阻滯的起搏治療 。 Gregoratos G. et al. ACC/AHA/NASPE 2021 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2021. Available at Level A 為最有力的證據(jù)。 ? IIa類 : ? 證據(jù) /意見偏向有用 /有效。 床表現(xiàn)。 Gregoratos G. et al. ACC/AHA/NASPE 2021 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2021. Available at III 類適應(yīng)證 : 慢性雙分支和三分支阻滯的起搏治療 Gregoratos G. et al. ACC/AHA/NASPE 2021 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2021. Available at Section IC: 與急性心肌梗死相關(guān)的房室阻滯的起搏治療 Gregoratos G. et al. ACC/AHA/NASPE 2021 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2021. Available at I 類適應(yīng)證 : 急性心肌梗死后的起搏治療 束系統(tǒng)內(nèi)或以下三度房室阻滯 (二度 或三度 ) 房室阻滯伴束支阻滯，如果阻滯部位不清楚則應(yīng)進行電生理檢查 Gregoratos G. et al. ACC/AHA/NASPE 2021 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2021. Available at IIa 類和 IIb 類適應(yīng)證 : 急性心肌梗死后的起搏治療 IIa類 : 無 IIb類 : ? 房室結(jié)水平的持續(xù)性二度或三度房室阻滯 Gregoratos G. et al. ACC/AHA/NASPE 2021 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2021. Available at III 類適應(yīng)證 : 急性心肌梗死后的起搏治療 支阻滯 Gregoratos G. et al. ACC/AHA/NASPE 2021 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2021. Available at Section ID: 竇房結(jié)功能不良的起搏治療 Gregoratos G. et al. ACC/AHA/NASPE 2021 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2021. Available at I 類適應(yīng)證 : 竇房結(jié)功能不良的起搏治療 , 包括引起癥狀的頻繁的竇性停搏 ?部分患者的竇性心動過緩是由于必須進行某些治療而又無其他可替代藥物的結(jié)果 Gregoratos G. et al. ACC/AHA/NASPE 2021 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2021. Available at IIa 類適應(yīng)證 : 竇房結(jié)功能不良的起搏治療 ，心率 40 bpm, 雖有心動過緩的癥狀，但未證實與所發(fā)生的心動過緩有關(guān) ，電生理檢查或激發(fā)試驗證實存在竇房結(jié)功能不良。 ，無論是否有癥狀（因為無法預(yù)測 AV傳導(dǎo)病變加重）。 Gregoratos G. et al. ACC/AHA/NASPE 2021 guideline update for implantation